Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions-Reference-Cited by-同舟云学术

Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions

Published:2021-08 Issue: Volume:53 Page:151766
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Martins Mariana Bonjiorno,de Assis Batista Fernando,Marcello Marjory Alana,Bufalo Natassia Elena,Peres Karina Colombera,Morari Elaine Cristina,Soares Fernando Augusto,Vassallo José,Ward Laura Sterian

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference41 articles.

1. Evolving understanding of the epidemiology of thyroid cancer;Seib;Endocrinol Metab Clin North Am,2019

2. Indeterminate thyroid nodules: a pragmatic approach;Khalil;Eur Thyroid J,2018

3. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed?;Haugen;Cancer.,2017

4. The Bethesda system for reporting thyroid fine-needle aspiration specimens;Crippa;Am J Clin Pathol,2010

5. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution;Theoharis;Thyroid,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitin-modifying enzymes in thyroid cancer：Mechanisms and functions;Heliyon;2024-07

2. Evaluation of 40-bp deletion/insertion polymorphism of mdm2 and 16-bp deletion/insertion polymorphism of p53 gene in patients with lymphoma in a Persian population;Genetika;2021